Section ofPlastic Surgery with Section ofSurgery 737 aesophagus and gives good results if used in selected cases by a skilled team. Debate continues regarding the precise indications for its use; also as to whether it is preferable to use stomach or colon and which route should be used, anterior or posterior mediastinal or presternal subcutaneous. Patients are generally able to leave hospital three to four weeks following successful surgery, with a satisfactory swallow and fair possibilities of regaining some useful speech (Figs 2, 3 & 4) .
Conclusions
Although it is correct to say that there has been little further improvement in curative treatment for these tumours over the past 10 years except in a better use of combined methods, there has been a more complete understanding of their surgical pathology (Harrison 1970 ) and a great improvement in the surgical techniques of repair and restoration of swallow. The most notable of these new techniques include the sophisticated use of large regional skin flaps from outside the irradiated areas, and the transposition of vascular pedicled gut segments. These have resulted in reduction of morbidity by cutting the time spent in hospital, with an earlier return of the normal swallow and an earlier start to speech therapy. The choice of technique remains important and much work must continue to be done to reduce the hazards of gut transposition, especially in irradiated and undernourished patients. A research project has been under way for seven years to determine the efficacy of intra-arterial infusion of methotrexate as a planned preliminary to standard surgical treatment of cancers of the mouth and jaw. This plan of combining intraarterial chemotherapy with surgery was decided on when it became obvious that intra-arterial methotrexate by itself produced only partial or temporary tumour regression.
The rationale for using a pre-operative intraarterial infusion of methotrexate was described and changes in the standard technique of intraarterial infusion were detailed. Reasons for such changes were enumerated. The advantages and disadvantages of intra-arterial methotrexate as a pre-operative tumour treatment were weighed and a description included of the typical kind of case in which pre-operative chemotherapy and ablative surgery are combined.
Mention was made of a method by which a tumour which crosses the mid-line can be effectively dosed with methotrexate, using only one portal of intra-arterial catheterization.
The more serious complications of this form of therapy were dealt with in some detail, and some statistics included, covering the first half of this ten-year project.
The conclusion is reached that there is a definite impression that, despite its limitations and its very definite hazards, intra-arterial infusion of methotrexate is avaluableadditionto the armamentarium in the battle against malignant disease of the head and neck. It is stressed that the real value of methotrexate lies in combining it with some other standard form of tumour treatment.
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